Neurodegeneration in Hepatic and Neurologic Wilson's Disease
- PMID: 33316133
- PMCID: PMC8453945
- DOI: 10.1002/hep.31681
Neurodegeneration in Hepatic and Neurologic Wilson's Disease
Abstract
Clinical presentation of Wilson disease (WD) includes hepatic and neurologic manifestations. This study compares subcortical brain regions by magnetic resonance imaging in patients with WD and without neurological symptoms. Distinct atrophy affecting the basal ganglia, accumbens, and hippocampus was present in neurological WD. Cerebellar atrophy was observed in hepatic WD without neurological symptoms.
© 2020 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Figures
References
-
- Ferenci P, Stremmel W, Członkowska A, Szalay F, Viveiros A, Stättermayer AF, et al. Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease. Hepatology 2019;69:1464‐1476. - PubMed
-
- Czlonkowska A, Tarnacka B, Moller JC, Leinweber B, Bandmann O, Woimant F, et al. Unified Wilson's Disease Rating Scale—a proposal for the neurological scoring of Wilson's disease patients. Neurol Neurochir Pol 2007;41:1‐12. - PubMed
-
- Dezortova M, Lescinskij A, Dusek P, Herynek V, Acosta‐Cabronero J, Bruha R, et al. Multiparametric quantitative brain MRI in neurological and hepatic forms of Wilson's disease. J Magn Reson Imaging 2020;51:1829‐1835. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
